Upping the ante on antibodies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16151393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The current generation of antibodies has done more than make a few companies rich. It has laid the groundwork for ambitious companies to move to maturity.
Medical subject headings
- Antibodies
- Biotechnology